SCHEMBL21498265

SCHEMBL21498265

Cc1cc(-c2cccc3c2C(=O)c2ccccc2-3)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ BRD4 O60885 1/20 0.45
▸ CREBBP Q92793 1/20 0.45
▸ PTGS2 P35354 4/20 0.43
▸ PTGS1 P23219 2/20 0.43
▸ ADORA2A P29274 2/20 0.42
▸ P2RY4 P51582 1/20 0.41
▸ TNKS2 Q9H2K2 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PTPRC P08575 2/20 0.39
▸ PTPN1 P18031 2/20 0.39
▸ S100A4 P26447 1/20 0.39
▸ ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21498275 0.82 ADORA2A (0.41) CYP1A1CYP1A2ADORA2AALDH1A1LMNA
SCHEMBL21498278 0.81 CYP1A1 (0.55) CYP1A1CYP1A2ADORA2AALDH1A1LMNA
SCHEMBL24796288 0.79 LMNA (0.46) CYP1A1CYP1A2ADORA2AALDH1A1LMNA
SCHEMBL19299387 0.78 CYP2A6 (0.52) CYP1A1CYP1A2ADORA2AALDH1A1LMNA
SCHEMBL19299618 0.78 RAB9A (0.48) CYP1A2ADORA2ALMNAMAPTMEN1
SCHEMBL19299405 0.77 MAOB (0.53) ADORA2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL23989075 0.77 MAPT (0.53) ADORA2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL30519266 0.76 ADORA2A (0.55) CYP1A2PTGS2PTGS1ADORA2AALDH1A1
SCHEMBL19283489 0.76 ADORA2A (0.55) CYP1A2PTGS2PTGS1ADORA2AALDH1A1
SCHEMBL21498269 0.76 LMNA (0.50) CYP1A2PTGS2PTGS1ADORA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11538996-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2022-12-27 — — US disclosed
EP-3419960-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-07-01 — — EP disclosed
US-10454041-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2019-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10454041-B2 Materials for organic electroluminescent devices RIF1, INTS9, LEF1 CYP1A1 20/4885CYP1A2 118/4885BRD4 2765/4885
US-11538996-B2 Materials for organic electroluminescent devices RIF1, INTS9, LEF1 CYP1A1 20/4885CYP1A2 118/4885BRD4 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback